Empowered Funds’s Apogee Therapeutics APGE Stock Holding History

Empowered Funds’s Portfolio APGE Stock Details APGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-2,065	Closed	-$274K	–	2521
2026 Q2	$274K	Buy	+2,065	New	+$186K	﹤0.01%	1891

Other funds holding APGE

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Allworth Financial Folsom, California $28.2B AUM 13.34% 1-Year Est. Return

Empowered Funds's APGE Position: Q3 2026 in Review

Empowered Funds sold out of Apogee Therapeutics (APGE) in Q3 2026, closing a stake of 2,065 shares — an estimated $274K sold.

Empowered Funds first reported a position in APGE in Q2 2026 and held it in 1 quarter. The position peaked at $274K in Q2 2026. 2 funds tracked by Wall St. Rank hold APGE as of Q3 2026.

Empowered Funds reported no remaining Apogee Therapeutics position as of Q3 2026 after selling out during the quarter.
Empowered Funds sold 2,065 Apogee Therapeutics shares in Q3 2026, an estimated $274K.
Empowered Funds first reported a position in Apogee Therapeutics in Q2 2026 and held it in 1 quarter.
Empowered Funds's Apogee Therapeutics position peaked at $274K in Q2 2026.
2 funds tracked by Wall St. Rank held Apogee Therapeutics as of Q3 2026.

Based on Empowered Funds's 13F filing for Q3 2026, filed 13 Nov 2026.